Elisabeth Zinser;Alexander STEINKASSERER;Matthias Lechmann
发明人:
Alexander STEINKASSERER,Matthias Lechmann,Elisabeth Zinser
申请号：
US13011380
公开号：
US20120015890A1
申请日:
2011.01.21
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
